A new peer reviewed study has found that Pfizer’s novel messenger RNA gene therapy Coronavirus Disease 2019 (COVID-19) vaccine reverse transcribes into human DNA in as little as six hours post-exposure.
In a paper published Feb. 25 in the journal Current Issues in Molecular Biology, researchers from Lund University in Sweden examined Pfizer-BioNTech’s BNT162b2 injection, which has been one of the two most widely distributed across the entire planet.
“The safety profile of BNT162b2 is currently only available from short-term clinical studies,” the team noted in the Introduction. “Less common adverse effects of BNT162b2 have been reported, including pericarditis, arrhythmia, deep-vein thrombosis, pulmonary embolism, myocardial...